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ABSTRACT                                                                                                                                            
Gene polymorphisms of TNF-α and IL-10 related to 
rheumatic heart disease
Enas Tawfik, Manal Abd El–Salam, Arwa Abd ulkarem and MonaYosseri
Pediatrics Department, Clinical pathology Department, Faculty of Medicine 
(for Girls), Al-Azhar University
Background: Rheumatic fever (RF) is inherited as a single recessive gene. 
Several genes are Likely to predispose an individual to develop rheumatic 
fever and rheumatic heart disease (RHD). Polymorphisms of TNF-α gene  were 
associated with susceptibility to develop RF.T cells from all rheumatic fever 
patients produce significant amounts of TNF-α in response to steptococcal 
peptides with the highest production attained by the chronic rheumatic heart 
disease patients,and IL-10 expression was characterized in heart tissue of RHD 
patients by immuno-histochemistry. 
Objectives: To test the relation of RHD and gene polymorphisms of pro-
inflammatory cytokines TNF-α gene at position -308 and anti–inflammatory 
IL-10 gene at position -1082.
Subjects and Methods: This study included 20 children with chronic 
rheumatic heart disease (group A) and 10 healthy children as a control group 
(Group B). Patients group was classified into patients with single and multiple 
valvular lesions, both of them were classified according to the severity by 
Echocardiography into: Group I: mild valvular lesion (n=7) Group II: Moderate 
lesion (n=4) Group III: severe lesion (n=9) Real time PCR was done for both 
TNF-α at-308 and IL-10 at position – 1082. 
Results: All cases showed significant higher frequency of TNF-α homozygous 
genotype G/G compared to control group (p <0.05,OR,11). Cases with severe 
valvular lesions showed increased frequency of homozygous genotype G/G 
and increased frequency of IL-10 genotype G/A in cases compared to control 
group (p ≤0.05,OR 13). There was no statistically significant difference in 
frequency of IL-10 genotypes among cases and control groups regarding to 
severity of valvular lesions. Composite genotypes (TNF-α G/G,IL-10 G/A) 
were higher in cases compared to control group (P ≤ 0.01), while composite 
genotypes (TNF-α G/A,IL -10 G/G) were higher in control group compared to 
cases groups. 
Conclusions: Susceptibility to RHD is associated with cytokine gene 
polymorphisms of TNF-α homozygous genotype G/G at-308 and IL-10 G/A 
at 1082. Composite genotypes (TNF-α G/G,IL-10 G/A) had high risk for 
RHD, while composite genotypes (TNF-α G/A,IL-10 G/G) may be protective 
genotypes.
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INTRODUCTION                                                                     
Acute rheumatic fever (ARF) causes 
an acute generalized inflammatory re-
sponse and an illness that selectively af-
fects the heart, joints, brain and skin. In 
spite of the dramatic response nature of 
acute episode of rheumatic fever (RF), 
it leaves no lasting damage to the brain, 
joints and skin1. but there is damage in 
the heart valves particularly the mitral 
and aortic valves that may persist after 
an acute episode has resolved2. Rheu-
matic heart disease (RHD) is a residual 
and progressive valve deformity result-
ing in stenosis or a combination of ste-
nosis and insufficiency which appears 
after an episode of acute RF.3 
Rheumatic fever is inherited as a single 
recessive gene. Several studies have 
suggested that genetic susceptibility to 
RF and RHD is linked to HLA class 
II alleles4. HLA class II genes are lo-
cated in human chromosome 6 and are 
often associated with susceptibility to 
auto- immune disease. There is a strong 
evidence that an auto-immune disease 
response to streptococcal antigens me-
diates the development of RF and RHD 
in susceptible host. Susceptibility to RF 
in certain individuals have been asso-
ciated with immunogenic, genetic and 
environmental factors.5
Cytokines appear to play a critical rule 
in triggering immunogenic and inflam-
matory reaction in rheumatic fever. 
Blood mono-nuclear cell culture from 
rheumatic children produced more TNF 
–α than those from controls6. Several 
genes are likely to predispose an indi-
vidual to develop RF. Polymorphisms 
of TNF-α gene were associated with 
susceptibility to rheumatic fever de-
velopment7. Polymorphisms in the 
promotor region of the TNF-α gene at 
nucleotide – 308 related to the tran-
scription start site may be important in 
determining the host TNF –α response8. 
IL-10 is also a cytokine that has well 
– documented an anti – inflammatory 
and immune – regulatory activities. 
IL-10 inhibits the synthesis of pro-in-
flammatory cytokines and chemokine 
by monocyte,macrophages, neutrophlis 
and eosinophils9. IL-10 is mainly pro-
duced by T helper 2 (TH2) subset of 
CD 4. However, it is also produced by 
some activated B cells. Kinetic studies 
demonstrated that IL-10 is synthesized 
later than other immuno regulatory cy-
tokines by activated T cells or mono-
cytes. This data may reveal the regu-
latory role of IL-10 in later phases of 
the immune response10. Also IL-10 is a 
prominent regulatory cytokine secreted 
by large numbers of cells in both valve 
and myocardium tissues11. The anti in-
flammatory cytokine interleukin-10 
(IL-10) inhibits monocyte production of 
pro – inflammatory cytokines including 
TNF-α. It also reduces MHC expres-
sion and attenuates recognition by cy-
totoxic lymphocytes12. Polymorphisms 
in the promotor region of IL-10 locus 
exhibit relevance in the pleiotropy of 
diseases of infectious, auto- immune or 
immune-responsive nature13. Polymor-
phisms of IL-10 change its production 
up to tenfold variation between indi-
35
Tawfik et al.
viduals14, A number of polymorphisms 
of promtor region have been character-
ized. Variable association between IL-
10 polymorphisms and IL-10 produc-
tion and auto-immune response have 
been reported.15
SUBJECTS AND METHODS                                   
This study included 20 children patients 
with chronic RHD, 7 males and 13 fe-
males and 10 sex and age matched ap-
parently healthy children (7 males and 
3 females) were included as a control 
group. Patients were selected from 
those attending the out patients cardiol-
ogy clinic of EL-Zahraa Hospital, AL-
Azhar University and Clinics of The 
General Organization For Teaching Na-
tional Heart Institute. Their age ranged 
from 5-15 years (Mean ages were 
11.5±2.6years). All patients were under 
regular follow up in outpatient cardi-
ology clinic. All patients were chosen 
not during the activity of RHD and free 
from congenital heart diseases. Chil-
dren with other immunological diseases 
were excluded. An informed consent 
was taken from each patient parent after 
explaining the purpose of the study.
Our studied patients were divided into 
two groups: The first group (Group A) 
compromised twenty patients of chron-
ic RHD while the second group (Group 
B) compromised ten apparently healthy 
children who had a negative family his-
tory of RHD as a control group.
According to echocardiography, valve 
lesions divided into single mitral valvu-
lar regurgitation (MR) (50%) and mul-
tiple valvular lesions as MR and aortic 
regurge (AR) (50%). Both single and 
multiple lesions of group A were sub-
divided according to echocardiography 
into mild (Group I), moderate (Group 
II) and severe RHD (Group III).
The studied groups were subjected to 
the following: 
1. Full history taking with emphasis 
on:
• Detailed history of RF (onset, dura-
tion, course of symptoms and pos-
sible associated symptoms).
• Past history including recurrent 
tonsillitis and tonsillectomy.
• Drug therapy (long acting penicil-
lin, salicylates, diuretics, corticos-
teroids and digoxin).
• Family history of similar condi-
tions. 
2. Clinical examination with special 
stress on cardiac examination.
3. Laboratory investigations which 
include:
• Anti streptolysin-O-titre (ASOT).
• The C-reactive protein (CRP).
• Erythrocyte sedimentation rate 
(ESR).
• Real time polymerase chain reac-
tion (PCR) for TNF-α and IL-10.
4. Chest-X-ray and electrocardio-
gram.
5. Echocardiogram. 
Specimen Collection and Methods 
For Real Time PCR:
Five ml of venous blood samples were 
collected aseptically from each sub-
ject in this study and divided into three 
tubes: 
• In the first tube 2ml were collected 
in sterile vacutainer tubes contain-
ing ethyenediamine tetra acetate 
(EDTA) and stored at -15 to -25°c 
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until used in DNA extraction and 
real-time PCR amplification for 
processing gene polymorphisms of 
TNF-ɑ gene at position -308 and 
IL-10 gene at position -1082.
DNA was extracted promptly using 
MagNA Pure Compact Nucleic Acid 
Isolation Kit I (Cat. No. 03730964001) 
supplied by (Roche, Germany).
Real time PCR amplification was 
done by Light Cycler-480 High Res-
olution Melting Master (Cat. No. 
04909631001). The kit is easy to use 
reaction mix (2× conc.) for PCR and 
high resolution melting using the Light 
Cycler® 480 Real Time PCR System 
(Roche, Germany).
• The second tube 0.8ml of blood 
were collected in sterile vacutain-
er tubes containing 0.2 Na citrate 
used to measure ESR by tradition-
al Westergren method read in 1st 
hour.16 
• The third tube contained the re-
maining portion of blood about 
2.2 ml. Serum is separated by cen-
trifugation. This serum is used to 
measure ASOT by using ASO latex 
agglutation slide kits and CRP by 
latex agglutation test.17
Statistical Analysis
Qualitative data were presented as fre-
quencies and percentages. Chi-square 
(χ2) test was used for studying the com-
parisons between different qualitative 
variables. Odds ratios (OR) and their 
95% confidence intervals (CI) were used 
to study the association between differ-
ent variables and valvular lesions. The 
(OR) is an estimate of relative risk.
Quantitative data were presented as 
minimum, maximum, means and stan-
dard deviation (SD) values. 
The significance level was set at P ≤0.05 
and P ≤0.01 (Highly significant) while 
P value >0.05 was insignificant. Statis-
tical analysis was performed with SPSS 
16.0 (Statistical Package for Scientific 
Studies) for Windows.
RESULTS                                                                       
TNF-α Genotypes:
Comparison between group A and group 
B regarding TNF-α genotype at -308 
showed, that homozygous genotype 
G/G is significantly higher in group A 
versus group B. On the other hand het-
erozygous genotype G/A is statistically 
significant higher in group B than group 
A. Homozygous genotype A/A showed 
no significant difference between group 
A and group B, (Table 1). 
Table 1: Comparison between TNF-α-308 genotypes among group A and group B:
TNF-ɑ
Genotypes
Grouop (A ) Cases (n= 20) Group (B) Control (n= 10)
P-value
Frequency % Frequency %
G/G 11 55 1 10 ≤0.05*
G/A 8 40 9 90 ≤0.01**
A/A 1 5 0 0 NS●
37
Tawfik et al.
Odds Ratio results shows a statistically 
significant strong association between 
There is significant increase in TNF-α 
genotype (G/G) in cases with severe 
valvular lesions (group III) compared 
to control group while genotype (G/A) 
showed statistically significant increase 
in group B than cases with severe val-
vular lesions (Table 3). Normalized and 
polymorphism of TNF-α at-308 (Figs 1, 
2). 
homozygous genotype G/G and RHD 
patients (Table 2).





Control (10) P-value Odds Ratio 95% CI
Frequency % Frequency %
+ve 11 55 1 10
≤0.05* 11.000 1.164-103.944-ve 9 45 9 90
Significant increase in TNF-α genotype 
(G/A) in group B compared to both 
mild, moderate and severe valvular le-
sions (Group I and II, III), respective-
ly. No significant difference regarding 
TNF-α (G/G) and (A/A) genotypes be-
tween group (B) and groups Ι, Π and III.
















Frequency % Frequency % Frequency % Frequency %
G/G 1 10 2 28.6 NS 2 50 NS 7 77.8 ≤0.05*
G/A 9 90 4 57.1 ≤0.05* 2 50 ≤0.05* 2 22.2 ≤0.05*
A/A 0 0 1 14.3 NS 0 0 NS 0 0 NS●
Fig. 1: Normalized and shifted melting curve of TNF-ɑ at position – 308.
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Fig. 2: Difference plots of polymorphism of TNF-ɑ at position – 308.
IL-10 genotypes:
Heterozygous G/A genotype is statis-
tically significantly higher in group A 
than group B while homozygous G/G 
and A/A genotypes showed no statis-
tically significant difference between 
group A and group B (Table 4). This in-
dicates statistical significant strong as-
sociation between IL-10 heterozygous 
genotype G/A and RHD (Table 5), nor-
malized and difference plots of IL-10 at 
position-1082 (Figs 3, 4).  






Frequency % Frequency %
G/G 1 5 3 30 NS●
G/A 18 90 5 50 ≤0.05 *
A/A 1 5 2 20 NS●







P-value Odds Ratio 95% CI
Frequency % Frequency %
+ve 18 90 5 50
≤0.05* 13.500 1.955-93.246-ve 2 10 5 50
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Fig. 3: Normalized and shifted melting curve of IL-10 at position – 1082.
Fig. 4: Difference plots of polymorphism of IL-10 at position – 1082.
ciation between composite genotypes 
(TNF-α G/G, IL-10 G/A) and RDH 
(Table 8) and (Fig 5).
IL-10 genotypes showed no significant 
difference between cases subgroups 
compared to control group (Table 6). 
Also there is high significant asso-
















Frequency % Frequency % Frequency % Frequency %
G/G 3 30 1 14.3 NS 0 0 NS 0 0 NS●
G/A 5 50 6 85.7 NS 3 75 NS 9 100 NS●
A/A 2 20 0 0 NS 1 25 NS 0 0 NS●
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Table 7: The odds ratios for association between composite genotypes (TNF-ɑ G/G, IL-10 G/A) and 






(n= 10) P-value Odds Ratio 95% CI
Frequency % Frequency %
+ve 10 50 0 0
≤0.01** 2.000 1.290-3.100

















TNF-α G/G, IL-10 G/A
Group A Group B
P≤0.01
P≤0.01
Fig. 5: Association between composite genotypes 
(TNF- α G/G,IL-10 G/A) and chronic RHD in 
group A and group B.
Also there is statistically significant as-
sociation between composite genotypes 
(TNF-α G/A, IL-10 G/G ) in group B 
(Control) than group A (Patients), so 
this composite genotype is considered 
as a protective genotype against RHD, 
(Tables 7 and 9) and (Fig. 6) Normal-
ized and difference spots of IL-10 poly-
morphisms at-1082 (Figs. 3, 4).








Frequency % Frequency %
TNF-ɑ G/G,
IL-10 G/G 1 5 1 10 NS●
TNF-ɑ G/G,
IL-10 G/A 10 50 0 0 ≤0.01**
TNF-ɑ A/A,
IL-10 G/A 1 5 0 0 NS●
TNF-ɑ G/A,
IL-10 G/G 0 0 2 20 ≤0.05*
TNF-ɑ G/A,
IL-10 A/A 1 5 2 20 NS●
TNF-ɑ G/A,
IL-10 G/A 7 35 5 50 NS●
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Table 9: The odds ratio for association between composite genotypes (TNF αG/A, IL-10 G/G) and 






(n= 10) P-value Odds Ratio 95% CI
Frequency % Frequency %
Yes 0 0 2 20

















TNF-α G/G, IL-10 G/A
Group A Group B
P≤0.05
P≤0.05
Fig. 6: Association between composite 
genotypes (TNF-G/A, IL-10 G/G) and chronic 
RHD in group A and group B.
DISCUSSION                                                                      
Rheumatic fever is an auto reactive dis-
ease secondary to group A streptococ-
cal (GAS) infection involving the heart, 
joints, skins and brain. Acute rheumatic 
fever (ARF) is an infective illness that 
has an impact on the heart and gives 
rise to chronic rheumatic heart disease2. 
Rheumatic fever and rheumatic heart 
disease continue to be an important 
cause of cardiovascular morbidity and 
mortality in developing world and ac-
count of all pediatric cardio admission. 
Carditis is the only manifestation of 
RF that leads to permanent disability. 
Recurrences’ of RF are likely to cause 
further damage of the heart with higher 
morbidity and mortality.18
The production of interlukine (IL) -10, 
TNF-α and IL-2 in the valvular lesions 
of ARF patients was correlated with 
Aschoff nodule progression. IL-1 and 
TNF-α were secreted by monocytes/
macrophages in stages 1 and 2, IL-2 
was secreted by T lymphocytes in stage 3. 
These results suggest a major role for 
inflammatory cytokines in mediating 
heart lesions in RF.11
WHO2 reported that the immune re-
sponse is genetically controlled with 
high responsiveness to streptococcal 
cell wall antigen which is being ex-
pressed through a single recessive gene 
and with low responsiveness through 
a single dominant gene. Immuno- his-
tochemical analysis of surgical heart 
tissue fragments from patients with 
RHD showed predominance of cells 
positive for TNF-α and IL-10 in lesion 
sites in both myocardium and valves11. 
The mononuclear cells from rheumatic 
heart lesions predominantly secrete 
INF-α and IL-10 in both myocardium 
and valves.19
Hafez, et al.20 found the relation be-
tween the degree of the  concentration of 
INF-γ and the severity of carditis which 
indicates variability in genetic suscepti-
bility and hence the degree of response. 
Tumor necrosis factor α is a potent im-
mune-modulator and pro-inflammatory 
cytokine that has been implicated in the 
pathogenesis of a large number of hu-
man diseases. The location of its gene 
within MHC and biological activities 
has raised the possibility that polymor-
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phisms within this locus may contribute 
to the pathogenesis of wide large auto-
immune and infectious diseases.21
Our study demonstrated that there is 
highly significant frequency of homo-
zygous genotype TNF-α G/G at posi-
tion-308 in cases (p <0.05, odd ratio= 2 
and 95% confidence interval ;CI) than 
control group. So there is significant 
strong association between homozy-
gous TNF-α -308 genotype G/G and 
RHD. 
On the other hand Settein, et al.22 stud-
ied polymorphisms of TNF-α gene at -308 
and found that TNF-α G/A was higher 
in cases compared to control group. The 
differences can be attributed to regional 
differences as well as difference in sam-
ple size.
Hernandes Pacheco, et al.23 reported 
that RHD is associated with TNF-α 
polymorphisms at position -308 in the 
Mexican population, he found that in-
creased frequencies of TNF-α G/A 
at-308 and found that TNF-α G/A at-
308 and decreased frequencies G/G 
genotype in cases compared to control 
group. The difference can be attributed 
to different races. In this work our re-
sults showed no significant difference 
in frequency of homozygous genotypes 
of TNF-α A/A and G/G of mild and 
moderate valvular lesions compared to 
control group. However in severe cases 
of RHD the frequency of homozygous 
genotype G/G was significantly higher 
in patients than in control group while 
the frequency of heterozygous geno-
type G/A is significantly higher in con-
trol group compared to cases.
On the other hand Settein, et al.22 found 
that patients with moderate severity 
showed high frequency of homozygous 
genotypes TNF-α A/A and G/G,while 
patients with severe lesions showed sig-
nificant high frequency of homozygous 
genotype A/A.
IL-10 is an important component of anti 
inflammatory cytokines network sup-
pressing gene expression and synthesis 
of pro-inflammatory cytokines24. In our 
study using real time PCR detected sig-
nificant increase in heterozygous geno-
types G/A of IL-10 at position -1082 
in cases (p ≤0.05, odds ratio, 13.5, CI, 
95%) than in control. So there was a 
statistically strong association between 
heterozygous G/A and RHD while ho-
mozygous G/G and A/A genotypes of 
IL-10 showed no statisticaly significant 
difference.
Settein, et al.22 reported that higher fre-
quency of homozygous A/A and G/G 
of IL10 at position -1082 with RHD. 
On the other hand there were studies 
of IL10 at -1082 with other diseases. 
Germano, et al.25 reported that IL10 
gene polymorphisms at –1082 and ex-
pression are important in determining 
susceptibility to Cardiomyopathy and 
Nemec, et al.26 reported that an associa-
tion between the -1082 G/A polymor-
phisms in IL10 gene promoter and the 
production of serum levels of rheuma-
toid factors in patients with rheumatoid 
arthritis. Our results showed no statisti-
caly significant differences in compari-
son between IL10 genotype frequency 
at -1082 with severity of RHD in cases 
groups compared to control. On the 
other hand Settin, et al.22 showed that 
homozygous genotype A/A was related 
to a more severe form of RHD.
The differences between our results and 
the other study may be related to sam-
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ple size, regional variations and also 
our work was done using real time PCR 
which is more accurate than PCR and 
this may account for conflicting results.
An auto regulatory loop appears to exist 
in which TNF-α Stimulates IL-10 pro-
duction which in turn reduces TNF-α 
synthesis. Stimulation of human blood 
samples with bacterial lipo-polysac-
charide showed large inter individual 
variations of IL10 and TNF-α produc-
tion suggesting a genetic component.27
In present  study our results  showed 
that composite genotypes of (TNF-ɑ 
G/G, IL-10 G/A) were  statistically 
significant high in cases compared to 
control  groups) (p value ≤0.01, Odds 
Ratio= 2, 95% CI), so there was asso-
ciation between composite genotype 
(TNF-ɑ G/G, IL-10 G/A) and the RHD 
while composite genotype (TNF-ɑ G/A, 
IL-10 G/G) showed statistically signifi-
cant higher in control group  than cases 
(p value ≤0.05, Odds Ratio= 3.5, 95% 
CI). So there was association between 
composite genotype (TNF-ɑ G/A, IL-
10 G/G) and control group.
Settin, et al.22 found that composite 
genotype of cases compared to control 
showed significantly high frequency in 
genotype TNF-α at-308 A/A with IL10 
at-1082 A/A. Also composite heterozy-
gous genotypes of TNF –α at-308 G/A 
and IL10 at- 1082 G/A was significant-
ly among control.
We suggest the discrepancy between 
our results and others could be attrib-
uted to different geographic distribution 
regional variations sample  size and 
methodology.
CONCLUSION                                                                      
Susceptibility to RHD is associated 
with certain cytokine gene polymor-
phisms that is considered a risk geno-
types as homozygous genotype TNF-ɑ 
at -308G/G and heterozygous genotype 
IL-10 at -1082 G/A, So they considered 
as risk genotypes.
• Cases with severe RHD was asso-
ciated with homozygous TNF-ɑ at 
-308 genotype G/G while heterozy-
gous genotype G/A had low risk 
for RHD and may be considered as 
protective genotype.
• Severity of RHD has no significant 
association with gene polymor-
phisms of IL-10 at -1082.
• Composite genotypes (TNF-ɑ G/G, 
IL-10 G/A)  had high risk for RHD 
while composite genotypes (TNF-ɑ 
G/A, IL-10 G/G) had low risk for 
RHD and may be regarded as pro-
tective genotypes.
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